Skip to content

Stepped Care for Aphasia

Stepped Care Model of Psychological Care for Aphasia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05851573
Enrollment
11
Registered
2023-05-09
Start date
2023-03-31
Completion date
2023-12-31
Last updated
2025-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aphasia, Stroke

Brief summary

This study is recruiting people who had a stroke at least 1 month ago and now have a language impairment called aphasia. Living with aphasia can have devastating effects on communication and quality of life, and it is not uncommon for survivors with aphasia to face psychological problems like depression and anxiety. Participants who are eligible for this study will undergo baseline testing, engage in a 5-week treatment focused on psychological well-being, undergo post-treatment testing, and then testing again 1-month later. Check-in phone calls will be conducted during the 1-month off period and participants will be interviewed about their experience at the end of the study as well. Compensation will be provided to participants with aphasia.

Interventions

BEHAVIORALPsychosocial intervention

an SLP-administered 5-week treatment focused on psychological well-being

Sponsors

Medical University of South Carolina
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 81 Years
Healthy volunteers
No

Inclusion criteria

* 18-81 years old * Native English speaker (English fluency by age 7) * Aphasia as a result of a left-hemisphere ischemic or hemorrhagic stroke (WAB-R Aphasia Quotient \< 93.8) * At least 1-month post-stroke * Confirmation of left hemisphere stroke per medical records * Discharged from hospital * Participant is willing and able to consent for themselves.

Exclusion criteria

* Uncorrected hearing or visual impairment that prevents completion of experimental activities as determined by self-report * History of other neurological disorder or disease beside stroke (e.g., dementia, traumatic brain injury) as determined by self-report and/or medical records * Self-reported history of premorbid learning disability * Severe auditory comprehension deficits (as indicated by a score of more than two standard deviations below norms on the Auditory Verbal section of WAB-R)

Design outcomes

Primary

MeasureTime frameDescription
Change in the Depression Score on Hospital Anxiety and Depression Scale at Post-Interventionthrough intervention completion, an average of 7 weeksChange in the total depression Hospital Anxiety and Depression Scale scores between baseline and post-treatment (baseline-post-treatment). Minimum score 0, maximum score 21. Positive scores indicate an improvement in symptoms, negative scores indicate a worsening in symptoms.
Change in the Anxiety Score on Hospital Anxiety and Depression Scale at Post-Interventionthrough intervention completion, an average of 7 weeksChange in the total anxiety Hospital Anxiety and Depression Scale scores between baseline and post-treatment (baseline-post-treatment). Minimum score 0, maximum score 21. Positive scores indicate an improvement in symptoms, negative scores indicate a worsening in symptoms.

Secondary

MeasureTime frameDescription
Change in Behavioural Outcomes of Anxiety Scale at Post-Interventionthrough intervention completion, an average of 7 weeksTotal score (min: 0, max: 30, higher scores indicate worse outcome); baseline-post-intervention; positive scores indicate an improvement in symptoms, negative scores indicate a worsening in symptoms.
Change in Modified Perceived Stress Scale at Post-Interventionthrough intervention completion, an average of 7 weeksTotal score (min: 0, max: 40, higher scores indicate worse outcome); baseline-post-intervention; positive numbers indicate an improvement in symptoms, negative numbers indicate a worsening in symptoms
Change in Dynamic Visual Analogue Mood Scales at Post-Interventionthrough study completion, an average of 7 weeksTotal summary score (min: 0, max: 100, higher scores indicate better outcome) and sadness score (min: 0, max: 100, higher scores indicate better outcome) (baseline-post-treatment). Positive number indicate worsening in mood, negative numbers indicate an improvement in mood.
Change in Communication Confidence Rating Scale for Aphasia at Post-Interventionthrough intervention completion, an average of 7 weeksTotal score (min: 10, max: 40, higher scores indicate better confidence); baseline-post-intervention, positive numbers indicate a worsening in communication confidence and negative numbers indicate an improvement in communication confidence
Change in Stroke Aphasia Quality of Life - 39 at Post-Interventionthrough intervention completion, an average of 7 weeksTotal score (min: 1, max: 5), baseline-post-intervention, positive numbers indicate a worsening of quality of life, negative numbers indicate an improvement in quality of life
Change in Stroke Aphasia Depression Questionnaire - 10 at Post-Interventionthrough intervention completion, an average of 7 weeksTotal score (min: 0, max: 30, higher scores indicate worse outcome); baseline-post-treatment; positive scores indicate improvement in symptoms, negative score indicate worsening of symptoms

Countries

United States

Participant flow

Pre-assignment details

Interested participants provided informed consent and were then screened to determine if they meet all eligibility criteria. After enrollment, all participants were assigned to the same intervention arm.

Participants by arm

ArmCount
Psychosocial Intervention
Psychosocial intervention: an SLP-administered 5-week treatment focused on psychological well-being
11
Total11

Baseline characteristics

CharacteristicPsychosocial Intervention
Age, Continuous57.6 years
STANDARD_DEVIATION 11.6
Cognitive Assessment of Stroke Patients30.3 units on a scale
STANDARD_DEVIATION 2.5
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
11 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Months Post-Stroke43.6 months
STANDARD_DEVIATION 41.1
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
3 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
8 Participants
Region of Enrollment
United States
11 participants
Sex: Female, Male
Female
3 Participants
Sex: Female, Male
Male
8 Participants
Western Aphasia Battery-Revised Aphasia Quotient74.0 units on a scale
STANDARD_DEVIATION 18
Years of Education15.8 years
STANDARD_DEVIATION 2.9

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 11
other
Total, other adverse events
0 / 11
serious
Total, serious adverse events
0 / 11

Outcome results

Primary

Change in the Anxiety Score on Hospital Anxiety and Depression Scale at Post-Intervention

Change in the total anxiety Hospital Anxiety and Depression Scale scores between baseline and post-treatment (baseline-post-treatment). Minimum score 0, maximum score 21. Positive scores indicate an improvement in symptoms, negative scores indicate a worsening in symptoms.

Time frame: through intervention completion, an average of 7 weeks

Population: One participant was excluded due to missing HADS data at post-intervention.

ArmMeasureValue (MEAN)Dispersion
Psychosocial InterventionChange in the Anxiety Score on Hospital Anxiety and Depression Scale at Post-Intervention0.40 units on a scaleStandard Deviation 4.3
p-value: =0.775t-test, 2 sided
Primary

Change in the Depression Score on Hospital Anxiety and Depression Scale at Post-Intervention

Change in the total depression Hospital Anxiety and Depression Scale scores between baseline and post-treatment (baseline-post-treatment). Minimum score 0, maximum score 21. Positive scores indicate an improvement in symptoms, negative scores indicate a worsening in symptoms.

Time frame: through intervention completion, an average of 7 weeks

Population: One participant was excluded due to missing HADS data at post-intervention.

ArmMeasureValue (MEAN)Dispersion
Psychosocial InterventionChange in the Depression Score on Hospital Anxiety and Depression Scale at Post-Intervention2.2 units on a scaleStandard Deviation 2.82
p-value: <0.05t-test, 2 sided
Secondary

Change in Behavioural Outcomes of Anxiety Scale at Post-Intervention

Total score (min: 0, max: 30, higher scores indicate worse outcome); baseline-post-intervention; positive scores indicate an improvement in symptoms, negative scores indicate a worsening in symptoms.

Time frame: through intervention completion, an average of 7 weeks

Population: One participant was missing data from this measure at baseline.

ArmMeasureValue (MEAN)Dispersion
Psychosocial InterventionChange in Behavioural Outcomes of Anxiety Scale at Post-Intervention2.00 units on a scaleStandard Deviation 3.01
p-value: 0.068t-test, 2 sided
Secondary

Change in Communication Confidence Rating Scale for Aphasia at Post-Intervention

Total score (min: 10, max: 40, higher scores indicate better confidence); baseline-post-intervention, positive numbers indicate a worsening in communication confidence and negative numbers indicate an improvement in communication confidence

Time frame: through intervention completion, an average of 7 weeks

ArmMeasureValue (MEAN)Dispersion
Psychosocial InterventionChange in Communication Confidence Rating Scale for Aphasia at Post-Intervention-.818 units on a scaleStandard Deviation 4.92
p-value: =0.593t-test, 2 sided
Secondary

Change in Dynamic Visual Analogue Mood Scales at Post-Intervention

Total summary score (min: 0, max: 100, higher scores indicate better outcome) and sadness score (min: 0, max: 100, higher scores indicate better outcome) (baseline-post-treatment). Positive number indicate worsening in mood, negative numbers indicate an improvement in mood.

Time frame: through study completion, an average of 7 weeks

ArmMeasureValue (MEAN)Dispersion
Psychosocial InterventionChange in Dynamic Visual Analogue Mood Scales at Post-Intervention-4.18 units on a scaleStandard Deviation 17.42
p-value: =0.444t-test, 2 sided
Secondary

Change in Modified Perceived Stress Scale at Post-Intervention

Total score (min: 0, max: 40, higher scores indicate worse outcome); baseline-post-intervention; positive numbers indicate an improvement in symptoms, negative numbers indicate a worsening in symptoms

Time frame: through intervention completion, an average of 7 weeks

ArmMeasureValue (MEAN)Dispersion
Psychosocial InterventionChange in Modified Perceived Stress Scale at Post-Intervention3.36 units on a scaleStandard Deviation 6.55
p-value: =0.119t-test, 2 sided
Secondary

Change in Stroke Aphasia Depression Questionnaire - 10 at Post-Intervention

Total score (min: 0, max: 30, higher scores indicate worse outcome); baseline-post-treatment; positive scores indicate improvement in symptoms, negative score indicate worsening of symptoms

Time frame: through intervention completion, an average of 7 weeks

Population: One participant was missing data on SADQ-10 at post-intervention

ArmMeasureValue (MEAN)Dispersion
Psychosocial InterventionChange in Stroke Aphasia Depression Questionnaire - 10 at Post-Intervention0.10 units on a scaleStandard Deviation 5.9
p-value: 0.959t-test, 2 sided
Secondary

Change in Stroke Aphasia Quality of Life - 39 at Post-Intervention

Total score (min: 1, max: 5), baseline-post-intervention, positive numbers indicate a worsening of quality of life, negative numbers indicate an improvement in quality of life

Time frame: through intervention completion, an average of 7 weeks

ArmMeasureValue (MEAN)Dispersion
Psychosocial InterventionChange in Stroke Aphasia Quality of Life - 39 at Post-Intervention-.093 units on a scaleStandard Deviation 0.258
p-value: =0.258t-test, 2 sided

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026